| Date Filed | Type | Description |
| 05/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/29/2020 |
4
| Piacquad David (SVP, Business Development) has filed a Form 4 on AMGEN INC|
Txns:
| Paid exercise price by delivering 116 shares
@ $236.28, valued at
$27.4k
|
|
| 03/24/2020 |
4
| Piacquad David (SVP, Business Development) has filed a Form 4 on AMGEN INC|
Txns:
| Paid exercise price by delivering 1,591 shares
@ $198.76, valued at
$316.2k
|
|
| 03/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2020 |
4
| Piacquad David (SVP, Business Development) has filed a Form 4 on AMGEN INC|
Txns:
| Sold 9,264 shares
@ $229.9308, valued at
$2.1M
|
|
| 12/13/2019 |
4
| Piacquad David (SVP, Business Development) has filed a Form 4 on AMGEN INC|
Txns:
| Paid exercise price by delivering 2,425 shares
@ $235.99, valued at
$572.3k
Exercised 2,875 options to buy
@ $162.6, valued at
$467.5k
|
|
| 11/20/2019 |
4
| Piacquad David (SVP, Business Development) has filed a Form 4 on AMGEN INC|
Txns:
| Paid exercise price by delivering 4,870 shares
@ $224.5, valued at
$1.1M
Exercised 5,749 options to buy
@ $156.35, valued at
$898.9k
|
|
| 05/07/2019 |
4
| Piacquad David (SVP, Business Development) has filed a Form 4 on AMGEN INC|
Txns:
| Paid exercise price by delivering 182 shares
@ $176.5, valued at
$32.1k
Granted 1,691 shares
@ $0
Granted 14,768 options to buy
@ $177.31, valued at
$2.6M
|
|
| 05/03/2019 |
4
| Piacquad David (SVP, Business Development) has filed a Form 4 on AMGEN INC|
Txns:
| Paid exercise price by delivering 171 shares
@ $179.3232, valued at
$30.7k
|
|
| 03/25/2019 |
4
| Piacquad David (SVP, Business Development) has filed a Form 4 on AMGEN INC|
Txns:
| Paid exercise price by delivering 1,509 shares
@ $191.89, valued at
$289.6k
|
|
| 03/08/2019 |
4
| Piacquad David (SVP, Business Development) has filed a Form 4 on AMGEN INC|
Txns:
| Granted 3,676 shares
@ $0 |
|
| 02/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/03/2018 |
4
| Piacquad David (SVP, Business Development) has filed a Form 4 on AMGEN INC|
Txns:
| Paid exercise price by delivering 4,109 shares
@ $202.37, valued at
$831.5k
Exercised 6,500 options to buy
@ $54.69, valued at
$355.5k
|
|
| 05/15/2018 |
4
| Piacquad David (SVP, Business Development) has filed a Form 4 on AMGEN INC|
Txns:
| Paid exercise price by delivering 9,860 shares
@ $170.77, valued at
$1.7M
Exercised 15,000 options to buy
@ $54.71, valued at
$820.7k
|
|
| 05/07/2018 |
4
| Piacquad David (SVP, Business Development) has filed a Form 4 on AMGEN INC|
Txns:
| Paid exercise price by delivering 178 shares
@ $169.43, valued at
$30.2k
|
|
| 05/01/2018 |
4
| Piacquad David (SVP, Business Development) has filed a Form 4 on AMGEN INC|
Txns:
| Granted 957 shares
@ $0
Granted 7,374 options to buy
@ $177.46, valued at
$1.3M
|
|
| 04/26/2018 |
4
| Piacquad David (SVP, Business Development) has filed a Form 4 on AMGEN INC|
Txns:
| Paid exercise price by delivering 217 shares
@ $171.94, valued at
$37.3k
|
|
| 03/27/2018 |
4
| Piacquad David (SVP, Business Development) has filed a Form 4 on AMGEN INC|
Txns:
| Paid exercise price by delivering 1,519 shares
@ $176.08, valued at
$267.5k
|
|
| 03/09/2018 |
4
| Piacquad David (SVP, Business Development) has filed a Form 4 on AMGEN INC|
Txns:
| Granted 4,031 shares
@ $0 |
|
| 01/30/2018 |
4
| Piacquad David (SVP, Business Development) has filed a Form 4 on AMGEN INC|
Txns:
| Paid exercise price by delivering 153 shares
@ $198, valued at
$30.3k
|
|
| 05/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/26/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/28/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/09/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/31/2017 |
4
| Piacquad David (SVP, Business Development) has filed a Form 4 on AMGEN INC|
Txns:
| Paid exercise price by delivering 160 shares
@ $157.16, valued at
$25.1k
|
|
| 05/05/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/28/2016 |
4
| Piacquad David (SVP, Business Development) has filed a Form 4 on AMGEN INC|
Txns:
| Paid exercise price by delivering 154 shares
@ $163.46, valued at
$25.2k
Paid exercise price by delivering 289 shares
@ $162.85, valued at
$47.1k
|
|
| 04/26/2016 |
4
| Piacquad David (SVP, Business Development) has filed a Form 4 on AMGEN INC|
Txns:
| Paid exercise price by delivering 210 shares
@ $163.19, valued at
$34.3k
|
|
| 03/29/2016 |
4
| Piacquad David (SVP, Business Development) has filed a Form 4 on AMGEN INC|
Txns:
| Paid exercise price by delivering 2,307 shares
@ $149.24, valued at
$344.3k
|
|